Recent work has identified L1CAM (CD171) as a novel marker for human carcinoma progression. Functionally, L1CAM promotes tumor cell invasion and motility, augments tumor growth in nude mice, and facilitates experimental tumor metastasis. These functional features qualify L1 as an interesting target molecule for tumor therapy. Here, we generated a series of novel monoclonal antibodies (mAb) to the L1CAM ectodomain that were characterized by biochemical and functional means. All novel mAbs reacted specifically with L1CAM and not with the closely related molecule CHL1, whereas antibodies to the COOH terminal part of L1CAM (mAb2C2, mAb745H7, pcytL1) showed cross-reactivity. Among the novel mAbs, L1-9.3 was selected and its therapeutic potential was analyzed in various isotype variants in a model of SKOV3ip cells growing i.p. in CD1 nude mice. Only therapy with the IgG2a variant efficiently prolonged survival and reduced tumor burden. This was accompanied by an increased infiltration of F4/80-positive monocytic cells. Clodronate pretreatment of tumor-bearing animals led to the depletion of monocytes and abolished the therapeutic effect of L1-9.3/IgG2a. Expression profiling of tumor-derived mRNA revealed that L1-9.3/IgG2a therapy induced altered expression of cellular genes associated with apoptosis and tumor growth. Our results establish that anti-L1 mAb therapy acts via immunologic and nonimmunologic effector mechanism to block tumor growth. The novel antibodies to L1CAM could become helpful tools for the therapy of L1-positive human carcinomas.
Therapeutic antibodies to human L1CAM: functional characterization and application in a mouse model for ovarian carcinoma.
S. Wolterink,G. Moldenhauer,M. Fogel,H. Kiefel,Marco Pfeifer,S. Lüttgau,R. Gouveia,Júlia Costa,J. Endell,U. Moebius,P. Altevogt
Published 2010 in Cancer Research
ABSTRACT
PUBLICATION RECORD
- Publication year
2010
- Venue
Cancer Research
- Publication date
2010-03-15
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
CONCEPTS
- chl1
A closely related L1 family molecule used here to test antibody specificity.
- clodronate pretreatment
Pre-treatment with clodronate used to deplete monocytes in tumor-bearing mice.
Aliases: clodronate depletion
- f4/80-positive monocytic cells
Monocytic immune cells identified by F4/80 staining in tumor tissue.
Aliases: F4/80+ monocytic cells, monocytes
- igg2a variant
The IgG2a isotype form of L1-9.3 evaluated in the mouse carcinoma model.
- l1-9.3
One of the newly generated anti-L1CAM monoclonal antibodies selected for in vivo testing.
- l1cam (cd171)
A human cell adhesion molecule used as the target antigen for the antibody panel in this work.
Aliases: CD171, L1
- novel monoclonal antibodies to l1cam ectodomain
A set of newly generated monoclonal antibodies directed against the extracellular domain of L1CAM.
Aliases: novel mAbs, L1CAM ectodomain antibodies
- skov3ip xenograft model
An intraperitoneal ovarian carcinoma mouse model built from SKOV3ip cells in CD1 nude mice.
Aliases: SKOV3ip cells growing i.p. in CD1 nude mice
REFERENCES
Showing 1-62 of 62 references · Page 1 of 1
CITED BY
Showing 1-77 of 77 citing papers · Page 1 of 1